P419 Clinical effectiveness and safety of first-line...

Journal of Crohn's and Colitis 2020 / 01 Vol. 14; Iss. Supplement

P419 Clinical effectiveness and safety of first-line biologic vedolizumab as a monotherapy or combination therapy in ulcerative colitis and Crohn’s disease patients: results from the EVOLVE study

Bressler, B, Yarur, A, Kopylov, U, Bassel, M, Brett, N, Colby, C, Lopez, C, Saha, S, Kifnidi, C, Agboton, C, Adsul, S, Demuth, D, Luo, M, Wang, S, Mantzaris, G J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.548
Date:
January, 2020
File:
PDF, 590 KB
2020
Conversion to is in progress
Conversion to is failed